Jonil Rutter News Today

Featuring Francis Collins, M.D., Ph.D., Senior Advisor to President Biden and Former Director of the National Institutes of Health, and Joni Rutter, Ph.D., NCATS Director, Plus a Panel...

Leaders from the National Institutes of Health and partner organizations outline NIH's COVID-19 research response in a policy forum in the journal Science.

America’s choices on key health care issues began to take shape overnight as results from several state ballot initiatives and governor’s races were called.

A large randomized, placebo-controlled clinical trial led by the National Institutes of Health shows that treating adults hospitalized with COVID-19 with infliximab or abatacept - drugs widely used to treat certain autoimmune diseases - did not significantly shorten time to recovery but did substantially improve clinical status and reduce deaths.

RESEARCH TRIANGLE PARK - The nearly 30 million Americans who suffer from rare diseases have received some good news. The National Institutes of Health, the U.S.

RESEARCH TRIANGLE PARK - The nearly 30 million Americans who suffer from rare diseases have received some good news. The National Institutes of Health, the U.S.

A new national public/private consortium designed to boost the development of gene therapies also holds promise for North Carolina, as a major global leader in cell and gene therapies.

While there are approximately 7,000 rare diseases, only two heritable diseases currently have FDA-approved gene therapies.

The National Institutes of Health, U.S. Food and Drug Administration, 10 pharmaceutical companies and five non-profit organizations have partnered to

A new, retrospective study of medical and insurance records indicates health care costs for people with a rare disease have been underestimated and are three to five times greater than the costs for people without a rare disease.